Helius Medical Technologies (HSDT)
(Delayed Data from NSDQ)
$1.29 USD
+0.05 (4.03%)
Updated May 29, 2024 03:59 PM ET
After-Market: $1.29 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Helius Medical Technologies, Inc. [HSDT]
Reports for Purchase
Showing records 21 - 40 ( 42 total )
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
3Q22: Revenue Increased YoY and QoQ, TEP Program Launched, Cash Thru 2023
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
MGH Institute of Health Professions is Fourth Group to Participate in TEP
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Oregon Health & Science University is Third Group to Participate in TEP
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
We are initiating coverage with a Buy rating and a 12-month price target of $5
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
C$9.2 Million Financing Not As Dilutive As It Could Have Been
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Helius Proposes Large Financing Shortly Before The End Of Its Funded TBI Registrational Trial
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Pilot PoNS Studies Planned By Third Parties For Various Indications
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Asian Distribution Agreement Signed That Includes $2 Million Investment and $5 Million Standby Commitment
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Stock Halves on August 4th Despite Being Roughly One Year From Approval In Canada - US
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
MS Pilot Moving As Planned, TBI Registrational Study Still Expected To Start This Month
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
US FDA Allows TBI Registrational Trial To Proceed
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Company: Helius Medical Technologies, Inc.
Industry: Medical - Instruments
Helius Alters US Listing Plans, Receives Second Patent.
Provider: Greenridge Global, LLC
Analyst: GREGOZESKI W